highly significantp = 0.008
By the period of 2004–2008, significant RER’s continued to exist for, stomach, colorectal, liver, lung, breast, prostate cancers, while RER variations in cervical and uterine cancers became highly significant ( p = 0.008 and 0.001 respectively).